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Acetone oxidation in rat liver microsomes was induced 5- or I-fold by the treatment of the animals with 
ethanol or acetone, respectively. The apparent K, of the reaction was 0.9 mM, a value lower than the con- 
centration reported for plasma acetone under starvation conditions. The major acetone metabolite was iden- 
tified as acetol by GC-MS. Acetone oxidation in microsomes was inhibited by typical P-450 inhibitors as 
well as by compounds (e.g. imidazole) known to interact with the ethanol-inducible P-450 form. Antibodies 
against this P-450 isozyme were inhibitory for the reaction in rabbit liver microsomes and this isozyme was 
the only one that showed acetone hydroxylation activity in reconstituted membranes. Imidazole inhibited 
the conversion of [Wlacetone into low-M, compounds (e.g. glucose) in vivo. It is suggested that the ethanol- 
and acetone-inducible P-450 make use of acetone as an endogenous ubstrate in the utilization of the com- 
pound for, e.g. glucose production under conditions of starvation and diabetic ketoacidosis. 
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1. INTRODUCTION 
Treatment of rabbits with ethanol or acetone 
causes the induction of a form of cytochrome 
P-450 in the liver microsomes called P-450 LMeb 
[ 1,2] or 3a [3-51. It appears that this form of P-450 
constitutes 20-40% of all cytochrome P-450 in 
liver microsomes from induced animals [4,5] and 
participates in the microsomal oxidation of 
ethanol and other aliphatic alcohols [2,4,6]. In the 
rat, similar forms of cytochrome P-450 are in- 
duced by ethanol, acetone and starvation (un- 
published). 
As shown by Reichard and collaborators [7,8], 
acetone appears to be a gluconeogenetic precursor 
in fasting and ketodiabetic humans. The plasma 
concentrations of acetone in such subjects are in 
the range l-10 mM [7,8]. At the smaller acetone 
concentration, 75% of the acetone produced is 
metabolized in vivo, especially to glucose [8]. This 
glucose production could account for 10% of the 
gluconeogenetic demands in fasting humans [7]. 
The work by Casazza et al. [9,10] has suggested 
that the hydroxylation of acetone to acetol is the 
first step in the conversion of the ketone to glucose 
and involves either a glyoxalate pathway or a 
metabolic route with propanediol as an in- 
termediary substance. 
During the course of our studies concerning 
benzene metabolism by the ethanol-inducible form 
of P-450, it turned out that acetone was a com- 
petitive inhibitor of the P-450 LMeb-dependent 
hydroxylation of benzene. It was therefore 
hypothesized that this form of cytochrome P-450 
would constitute an effective catalyst for acetone 
hydroxylation. Here, we present evidence that this 
indeed is the case and that the K,,, of the enzyme 
for acetone is smaller than the plasma concentra- 
tions of this substance under fasting conditions. 
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2. EXPERIMENTAL 
Male Sprague-Dawley rats (175 g) were starved 
for 24 h and subsequently treated with acetone 
(5 ml/kg) as described [Xl]. Other groups of rats 
were treated with ethanol according to DeCarli and 
Lieber [ 121. Control rats received food and water 
ad libitum until killing. The livers of the animals 
were homogenized in 3 vols of 10 mM 
sodium/pot~sium phosphate buffer, pH 7.4, con- 
taining 1.14% KCl. The microsomes were 
prepared by ultracentrifugation and washed once 
before suspension in 50 mM potassium phosphate 
buffer, pH 7.4. Acetone metabolism was studied 
using 14C-labelled substrate, The incubations were 
performed in sealed tubes with liver microsomes 
corresponding to 1 mg protein in the presence of 
1.36 mM acetone containing 0.4 &i 14C-labelled 
substrate in a total volume of 1 ml of 50 mM 
potassium phosphate buffer, pH 7.4. The incuba- 
tions were started by the addition of 0.4 mg 
NADPH and stopped by the addition of 0.1 ml of 
4OVo trichloroacetic acid. The tubes were subse- 
quently treated with a stream of nitrogen at 56°C 
for 15 min and the residues were allowed to stand 
at room temperature for 48 h. Aliquots of lO0/11 
were counted in a scintillation counter after addi- 
tion of water to the original volume. Acetone 
metabolites were also analyzed as dinitrophe- 
nylhydrazone derivatives [13] and subjected to 
analysis on HPLC. Metabolites eluted from the 
HPLC were further derivatized using rert-butyl- 
dimethylchloros~~e (tBDMClS) and analyzed by 
gas chromatography-mass spectrometry (GC-MS) 
[14]. Acetol was obtained from Aldrich, 
2,4_dinitrophenylhydrazine from Riedel-De Haen, 
phenylhydrazine chloride from Merck and 
tBDMClS was purchased from Janssen, Beerse, 
Belgium. 
Carbohydrates were analyzed in livers from rats 
receiving i.p. injections of [14C]acetone. The livers 
were homogenized in 1 vol. redistilled water and 
ethanol was added to 80% (v/v). The samples were 
subsequently centrifuged and the supernatants, 
containing e.g. small ~bohydrates, lipids and 
amino acids, were evaporated to dryness. The 
residues were dissolved in 5 ml water and an ali- 
quot measured for radioactivity. Carrier &cose 
(3 mg), phenylhydrazine chloride (67 mg) and 
sodium acetate (100 mg) were added and the 
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samples boiled for 30 min. The resulting osazones 
were collected by centrifugation, washed once in 
cold water and dissolved in 1 mI acetone : methanol 
(1: 1, v/v) and subjected to TLC using the solvent 
system acetone : methanol (95 : 5, v/v). The glucose 
band was scraped off the plate and analyzed for 
radioactivity using a scintillation counter and 
Aqualuma plus as scintillator liquid. 
3. RESULTS 
The oxidation of acetone in control microsomes 
or microsomes isolated from acetone-treated rats 
was linear for 20 min under the conditions used 
(not shown). The substrate curves obtained using 
the two types of microsomes (fig-l) revealed a lu, 
of slightly less than 1 mM (table 1). The Vmpx in 
acetone microsomes was at least IO-fbld higher 
than in control microsomes (table 1). In 
microsomes from ethanol-treated rats, the rate of 
acetone oxidation was 5-fold higher, compared to 
control (table 1). 
The microsomal oxidation of acetone was in- 
hibited by compounds known to interact with the 
ethanol-inducible form of cytochrome P-450 
(benzene, aniline, ethanol and imidazole, cf. [2,4]) 
as well as by typical cytochrome P-450 i~ibitors 
(table 2). In contrast to the situation when analyz- 
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Fig.1. Effect of substrate concentration on the rate of 
acetone oxidation in liver microsomes isolated from 
acetone-treated (o----o) and control (M) rats. 
Incubations were performed as described in section 2 
with liver microsomes corresponding to 1 mg protein for 
20 min at 37%. 
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Oxidation of acetone by liver microsomes from control, ethanol- and acetone-treated rats 
Type of liver 
microsomes 
Acetone oxidation 
nmol/mg per min nmol/nmol per min 
V 
(nmol/m~~er min) 
Control (4) ‘0.20 f 0.03 0.35 * 0.07 0.80 0.25 
Ethanol (6) 1.11 f 0.23b 0.81 + 0.19” 
Acetone (5) 1.53 + 0.17b 1.23 f 0.20b 0.99 2.6 
’ p < 0.005; b p < 0.001, compared to control 
The turnover values were obtained from incubations performed with 1.36 mM acetone and microsomes corresponding 
to 1 mg protein from the number of animals indicated within parentheses 
ing the microsomal ethanol oxidation (cf. [2]), ad- 
dition of Fe-EDTA was inhibitory for product for- 
mation and mannitol was a weak scavenger of the 
reaction (table 2). To evaluate further the par- 
ticipation of the ethanol-inducible form of 
cytochrome P-450, liver microsomes from acetone- 
treated rabbits were incubated with acetone in the 
presence of antibodies towards this form of P-450 
Table 2 
Effect of Fe(III)-EDTA, mannitol, inhibitors of 
cytochrome P-450 and compounds known to interact 
with the ethanol-inducible P-450 form on the rate of 
acetone oxidation in liver microsomes from acetone- 
treated rats 
Inhibitor added Acetone 
oxidation 
(nmol/mg 
per min) 
Inhibition 
(%) 
None 1.44 - 
Aniline, 1 mM 0.04 97 
Ethanol, 200 mM 0.04 97 
Mannitol, 500 mM 1.05 27 
Imidazole, 0.05 mM 1.25 13 
0.5 mM 0.29 80 
5mM 0 100 
SKF-525A, 0.2 mM 0.78 46 
Metyrapone, 1 mM 1.27 12 
Fe-EDTA, 10 CM 0.48 67 
Carbon monoxide 0.03 98 
Benzene, 0.1 mM 0.36 75 
1mM 0.14 90 
The substrate concentration was 1.36 mM and the 
conditions as outlined in section 2 
(P-450 LMeb). As seen from fig.2, control IgG had 
a slight stimulatory effect on the reaction, whereas 
anti-P-450 LMeb-IgG was inhibitory. The acetone 
hydroxylation was also reconstituted in mem- 
branes containing various forms of rabbit liver 
microsomal cytochromes P-450 and NADPH- 
cytochrome P-450 reductase. The ethanol- 
inducible P-450 form was the only one that showed 
significant activity (table 3). 
To identify acetone metabolites produced in the 
microsomal system, the incubation residues (cf. 
section 2) were derivatized and analyzed by HPLC 
and GC-MS. As is evident from fig.3, two major 
acetone metabolites were eluted from the HPLC 
column. The first one (I) had identical retention 
time as did dinitrophenylhydrazine-derivatized 
0 12 3 L 5 
Fig.2. Inhibition of the liver microsomal NADPH- 
dependent oxidation of acetone by antibodies towards 
the ethanol-inducible form of cytochrome P-450 (P-450 
LMeb). The anti-P-450 LMeb-IgG was prepared as in [4] 
and added 15 min prior to the initiation of the 
incubations. 
61 
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Table 3 
Oxidation of acetone in reconstituted membrane vesicles 
containing various forms of rabbit liver microsomal 
cytochrome P-450 and NADPH-cytochrome P-450 
reductase 
Cytochrome used 
P-450 LMz 
P-450 LMeb 
P-450 LM4 
nmol/nmol P-450 per min 
< 0.02 
0.15 
< 0.02 
The sources of enzymes [2] and procedures for 
preparation of membrane vesicles [ 151 were as described. 
The membranes contained P-450 reductase : P-450 : 
phospholipid at a molar ratio of 1: 4 : 1200. Incubations 
were performed with 1.36 mM acetone and vesicles 
corresponding to 0.2-0.45 nmol P-450 for 20 min 
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acetol and, furthermore, after derivatization with 
tBDMClS, exhibited an identical mass spectrum as 
authentic dinitrophenylhydrazine- and tBDMClS- 
derivatized acetol (fig.3). This metabolite was 
therefore identified as acetol. Approx. 30% of the 
total radioactivity in the incubation residues was 
recovered in the organic phase after dinitro- 
phenylhydrazine derivatization. 
Imidazole, a compound that has been previously 
found to interact with P-450 LMeb (cf. [4]), was a 
very effective inhibitor of acetone hydroxylation in 
vitro (table 2). It was therefore proposed that ad- 
ministration of this compound to rats prior to the 
injection of [i4C]acetone to the same animals 
should prevent the in vivo incorporation of 
radioactivity into glucose and other low-M, com- 
pounds. As is evident from table 4, imidazole given 
0 1c 20 30 LO 
fraction number 
Y” 
Y ‘;3 ,CH3 
CH3-C-CHy0-:I-C-CH~ 
131 
C"3 '("3 '2" 
Fig.3. HPLC (A) and W-MS (B) analysis of acetone metabolites produced from incubations with liver microsomes 
of acetone-treated rats. After termination, the incubations were derivatized with 2,4_dinitrophenylhydrazine and 
extracted with chloroform [13]. The organic phase was taken to dryness under nitrogen and dissolved in ethyl acetate 
before injection onto the HPLC column (crBondapack Cis). The column was eluted isocratically with methanol: water 
(1: 1, v/v) at a rate of 1.5 ml/min. Fractions corresponding to peak I and II, respectively, were pooled, taken to dryness 
under nitrogen and further derivatized with tBDMClS [14]. Aliquots corresponding to 0.5 nmol substance were 
analyzed on an LKB 2091 gas chromatograph-mass spectrometer, equipped with a fused-silica capillary column with 
a chemically bonded polydimethylsiloxane phase, CPSil 5 CB (Chrompack, Middelburg, The Netherlands). The column 
temperature was 225°C and the mass spectra were recorded at an electron energy of 22.5 eV and an ion source 
temperature of 310°C. The m/z 115, 75 and 73 represent fragments from the tBDMS groups. The m/z 353 represents 
the loss of a methyl group (M - 15) and m/z 311 is equivalent with loss of the t-butyl group (M - 57) from the derivatized 
acetol. The upper part of (B) shows the spectrum obtained using the authentic compound and the lower part is that 
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Incorporation of [‘4C]acetone into low-M, compounds and carbohydrates in livers from starved and 
acetone-treated rats 
Type of treatment 14C incorporation (cpm/g liver) 
LOW-M; Osazone derivates Glucose 
compound of carbohydrate 
None (4) 23000 f 4500 4100 f 900 580 f 110 
Imidazole, 200 mg/kg (4) 11900 f 3700* 430 f 160b 190* 60b 
ap < 0.01; bp c 0.001, compared to control 
The results are given as mean f SD from the number of animals given within parentheses. The rats were 
given acetone intragastrically (5 ml/kg) on day 1 and starved day 1 and 2. Imidazole (100 mg/ml in water) 
was injected i.p. into one group of rats on day 3. 3 h later, 4 /rCi [‘4C]acetone was injected i-p. into all 
animals. The rats were killed after a further 3 h period and low-M, compounds in the livers were analyzed 
as described in section 2 
at a dose of 200 mg/mg (yielding approx. 3-5 mM 
extracellular concentration) 3 h before [14C]- 
acetone, inhibited the conversion of radioactive 
acetone into carbohydrates by 90% and the incor- 
poration of radioactivity into specifically glucose 
by 67%. 
4. DISCUSSION 
Our results indicate that acetone- and ethanol- 
inducible cytochrome P-450 form(s) are responsi- 
ble for the micro$omal metabolism of acetone to 
oxygenated products being able to undergo further 
metabolism to intermediates participating in the 
gluconeogenetic pathway. The extent of inhibition 
by imidazole in vitro of the cytochrome 
P-&O-dependent acetone oxidation correlated well 
with the findings in vivo regarding the ability of 
imidazole, at similar concentrations, to prevent he 
incorporation of [‘4C]acetone into low-M, car- 
bohydrates, such as glucose. The apparent J&,, of 
the reaction in microsomes of about 0.9 mM is 
lower than the acetone concentrations in plasma 
reported under starvation and conditions of 
ketoacidosis [7,8]. 
The inhibition by aniline, ethanol and benzene 
of the microsomal acetone oxidation indicates the 
utilization of a common cytochrome P-450- 
dependent metabolic site for these substrates. The 
absence of a stimulator effect of Fe-EDTA on the 
reaction, which is in contrast to the situation con- 
cerning the cytochrome P-450-dependent ethanol 
oxidation 12,161, indicates the existence of 
mechanisms for acetone hydroxylation not involv- 
ing the participation of free hydroxyl radicals. 
The induction of the ethanol-inducible form of 
cytochrome P-450 by acetone and of similar 
cytochrome P-450 forms in the rat also by starva- 
tion indicates that acetone might be of highly 
physiological importance as an inducing agent of 
cytochrome P-450 under starvation and diabetic 
conditions. Furthermore, it appears that acetone 
may be one of the quantitatively most important 
endogenous substrates for cytochrome P-450 
under these conditions. 
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